Top 50 Biotechnology Startup Investors in Austria in January 2026
A list of 50 angel investors and VC (Venture Capital) funds that invest in Biotechnology startups based in Austria. We rank investors based on the number of investments they made in Biotechnology companies from Austria. We update this investor list every month.Top 50 Biotechnology Startup Investors in Austria in January 2026
| Investor | Biotechnology Austria investments |
|---|---|
| xista science ventures | 10 |
| xista science ventures | 9 |
| tecnet equity | 6 |
| austria Wirtschaftsservice (aws) | 5 |
| SOSV | 5 |
| MIG Capital | 4 |
| aws Gründungsfonds | 3 |
| Schnidar Harald | 3 |
| Longevitytech.fund | 2 |
| Aescap Venture | 2 |
| Übermorgen Ventures | 2 |
| TSVC | 2 |
| Lansdowne Partners | 2 |
| 10x Founders | 2 |
| R42 Group | 2 |
| FPS-Holding | 2 |
| APEX Ventures | 2 |
| red-stars.com | 2 |
| bmp Ventures | 2 |
| Arax Capital Partners | 2 |
| The Austrian Research Promotion Agency (FFG) | 2 |
| BackBone Ventures | 2 |
| Nina Capital | 2 |
| APEX Ventures | 2 |
| PUSH VC | 2 |
| Fund F | 1 |
| Lansdowne Investment Company Cyprus | 1 |
| EIT Health | 1 |
| INVEST AG | 1 |
| Pace Ventures | 1 |
| FastVentures | 1 |
| Clima Now | 1 |
| SFG Steirische Wirtschaftsförderungsgesellschaft m.b.H | 1 |
| 42CAP | 1 |
| Gamma Capital Partners | 1 |
| Matthias Wilrich | 1 |
| Santo Holding | 1 |
| ICL Planet Startup Hub | 1 |
| HCVC | 1 |
| ReGen Ventures | 1 |
| Tet Ventures | 1 |
| Possible Ventures | 1 |
| Andera Partners | 1 |
| MCI Capital SA | 1 |
| Kale United | 1 |
| eQventure | 1 |
| Gateway Ventures | 1 |
| VP Venture Partners | 1 |
| 4SC | 1 |
| Air Street Capital | 1 |
We invest in deep tech startups and academic spin-offs with a strong innovation based on science, engineering and technology. We invest as lead investor in pre-seed and seed stages and have the ability to follow on in later rounds. We understand the needs of science and tech based startups and offer tailored support for entrepreneurs. We areembedded in the venture capital scene, yet understand the language of science and the world of research. Thanks to our diverse team, our expertise and experience in technology, entrepreneurship, finance, legal, IP, and strategic consulting will support your startup right from the start.
Show more
Investment focus
- Biotechnology, Medical, Medical Device
- Seed, Pre-Seed, Series A
- Austria, France, Slovenia
Portfolio highlights
- Syntropic Medical GmbH — Syntropic is a medical device company that develops novel technologies that helps for the treatment of psychiatric diseases and the improvement of cognitive abilities.
- G.ST Antivirals — G.ST Antivirals focuses on the development of antiviral drugs. G.ST Antivirals utilizes the viral dependency on the host cell metabolism and exploits this to design specific interventions counteracting viral nutrient supply.
- HEPHAISTOS-Pharma — Hephaistos Pharma is a developing weapons firm. They provide services for oncology, immunotherapy, and cancer. An online inquiry form is available on the company's website.
We invest in deep tech startups and academic spin-offs with a strong innovation based on science, engineering and technology. We invest as lead investor in pre-seed and seed stages and have the ability to follow on in later rounds. We understand the needs of science and tech based startups and offer tailored support for entrepreneurs. We areembedded in the venture capital scene, yet understand the language of science and the world of research. Thanks to our diverse team, our expertise and experience in technology, entrepreneurship, finance, legal, IP, and strategic consulting will support your startup right from the start.
Show more
Investment focus
- Biotechnology, Medical, Software
- Seed, Pre-Seed, Series A
- Austria, Slovenia
Portfolio highlights
- subdron — subdron focuses on data processing in underwater inspections and autonomous underwater navigation.
- infrared.city — Redefine environmental simulations. Our bespoke AI models revolutionise performative design, slashing time, cost, and complexity. Access cutting-edge services effortlessly because innovation should be for everyone
- VALANX Biotech — VALANX Biotech is a site-specific protein conjugation platform to enable fast and cost efficient protein-drug-conjugates development.
tecnet equity is an Austrian venture capital fund investing in innovative high-tech companies with potential for significant growth.
Show more
Investment focus
- Software, SaaS, Information Technology
- Seed, Funding Round, Series A
- Austria
Portfolio highlights
- Sipfront — Sipfront helps telecom operators to deliver better services by automating 24/7 active monitoring and by providing a test framework to simulate customer calls at scale
- Orderlion — Streamline your wholesale business with Orderlion's ordering app. Automate orders, boost sales, and enhance customer loyalty. Find out more!
- VALANX Biotech — VALANX Biotech is a site-specific protein conjugation platform to enable fast and cost efficient protein-drug-conjugates development.
The Austrian Economic Service mbH (aws) is the promotional bank of the Federal Government.The aws SME fund is the largest Austrian Fund for silent corporate investments, but also providers of equity. Founded in late 2009 by the Austrian Economic Service mbH (aws) - the Development Bank of the Federal - he has a term until 31/12/2025.The fund is currently endowed with EUR 80 million and participates in medium-sized companies and brings with it a fresh capital to develop new products or processes, for sales development to international expansion.
Show more
Investment focus
- Software, Information Technology, SaaS
- Seed, Grant, Pre-Seed
- Austria, Belgium
Portfolio highlights
- HD Immune — HD Immune develops an antibody to target the mutated protein and remove it from the body. HDI has a lead antibody mAB C6-17 which lowers mtHTT in the blood and organs.
- Aitiologic — aitiologic is an Austrian precision medicine startup developing ai-powered solutions for early disease detection and targeted therapy.
- Aileen Health — Medical images detect tumors. What if they helped clinicians look ahead too, for guided therapy selection? Meet the GenAI companion Cancer4D.
SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates.
HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more
Investment focus
- Biotechnology, Health Care, Software
- Seed, Convertible Note, Pre-Seed
- United States, India, United Kingdom
Portfolio highlights
- MixRift — MIXRIFT - game developers specialized in Mixed Reality
- unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
- Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
MIG Capital is one of the leading German VC Investors. We invest in European Deep Tech and Life Sciences from early to late stage (Seed, Series A, and beyond). We use investments to shape a better tomorrow, today. Our team currently manages 17 MIG public venture capital funds regulated by BaFin, the German financial markets authority. These fundsoperate with more than EUR 1.2 billion capital committed by >60,000 private investors across Germany and Austria.Today, our portfolio consists of 30 companies.
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Series A, Funding Round, Series B
- Germany, France, Austria
Portfolio highlights
- AMSilk — AMSilk produces and distributes high-quality silk biopolymers for use in textile products, medical devices, and cosmetics.
- Look Up Space — Lookup space is the next global leader for space safety, security and sustainability
- ASTRA Therapeutics — Astra - Therapeutics
aws Gründerfonds is Austria's 70m venture capital fund. We invest as co-investor in Austrian high-growth start-ups in their later seed and (pre-)series-A stages.
Show more
Investment focus
- Software, SaaS, Information Technology
- Seed, Series A, Funding Round
- Austria, United States, Germany
Portfolio highlights
- OPTIMUSE — Optimuse provides an AI-based solution that supports the pre-design phase of building renovation. The platform converts building data into a digital twin to create accurate models for planning. It integrates data such as room types, thermal properties, and HVAC systems. The system runs energy simulations to calculate heating, cooling, lighting, andequipment needs. It helps design technical systems by defining the quantity, sizing, and configuration of components. The platform develops renovation plans by modeling financial, energy, and emissions outcomes. It also offers tools for cost calculation, performance monitoring, and collaboration across project teams.
- Planted Green — Planted Green plants mixed forests to compensate for CO2 emissions.
- HelloBello — HelloBello offers freshly cooked and cooled delivered human-grade food tailored to each dog’s nutritional needs. HelloBello is a PetTech company with a strong focus on the German speaking markets (for now). HelloBello’s personalized meals are free of any by-products and are portioned, packaged, and delivered directly to your door. By working with aspecialized veterinarian, HelloBello is able to derive each dog’s exact nutritional needs based on a proprietary algorithm. The recipes are made of natural sources like millet and seaweed, instead of heavy use of supplements, which makes it easier for the dog to absorb and get true nutritional benefits.Our credo in German is " ... Frisch. Individuell. Geliefert. - Frischfutter ist einfach besser ..."
Entrepreneur, Angel Investor, Scientist and Inventor
Show more
Investment focus
- mHealth, Software, Biopharma
- Seed, Angel, Pre-Seed
- Austria
Portfolio highlights
- SCARLETRED — SCARLETRED is an international Digital Health Scaleup revolutionising the global skin care market by the AI powered SCARLETRED®VISION platform system. The problem we solved is subjective skin assessment and lacking standardization in Dermatology. Our medical device certified platform is fully mobile, runs via mobile App on smartphones and connectsto our web platform, which enables to generate smart imaging data and novel AI decision support applications in Dermatology and Telemedicine. The multi award winning technology is supplied international via SaaS to Biopharma and Cosmetics Industry, Hospitals and Medical Experts. Protected via worldwide patents it facilitates standardized skin documentation and remote tracking of skin changes and therapeutic effects via mobile App. Images can be uploaded in a cloud based platform and objectively analysed for visual skin changes over time, such as for allergic reactions, pigmentation changes, acne, psoriasis, disease or wound healing. SCARLETRED provides services on a broad range of dermatologic conditions ranging from B2B to B2B2C applications.
Investing globally in technologies extending healthy lifespans
Show more
Investment focus
- Biotechnology, Health Care, Personal Health
- Seed, Convertible Note, Pre-Seed
- United States, United Kingdom, The Netherlands
Portfolio highlights
- Klothea Bio — Klothea Bio is a protein well known for its powerful anti-aging capabilities, such as tumor suppression, neuroprotection, and antioxidative actions. As people age, their klotho levels drop to harmful levels. The metabolic disease syndrome will be the focus of the first investigations, while later studies will try to extend therapeutic applicationsto cancer, Alzheimer's disease, obesity, and other age-related diseases.
- Yuva Biosciences — Using cutting edge mitochondrial science to develop cosmeceuticals and pharmaceuticals.
- MitoRx Therapeutics — Developing revolutionary mitochondrial-protective therapeutics which reverse mitochondrial dysfunction to arrest decline in muscular dystrophy and neurodegeneration. MitoRx Therapeutics' first-in-class first-in-target platform has potential to arrest the progression of some of the most challenging diseases.
The Aescap funds invest in the most promising innovative listed biotech companies with exceptional growth potential
Show more
Investment focus
- Biotechnology, Pharmaceutical, Chemical
- Series A, Series B, Funding Round
- United Kingdom, Austria, Belgium
Portfolio highlights
- Orphazyme — Orphazyme develops innovative new therapies for the treatment of a family of serious genetic disordes called lysosomal storage diseases, and is based on discoveries emerging from the academic laboratory of its scientific founders: Professor Marja Jäättela and Thomas Kirkegaard Jensen from the Danish Cancer Society (Kræftens Bekæmpelse).Orphazyme is based in Copenhagen and has established collaborations with top-tier academic institutions in Europe and USA.
- Avantium — Build a sustainable future with Avantium. Leading the change in green chemistry and innovative solutions.
- F-Star Therapeutics — F-star is a clinical stage biotech developing next generation immunotherapies to transform the lives of patients with cancer. We are developing transformational cancer immunotherapies for patients who have few remaining options.
We are an early stage VC for climate tech startups.
Show more
Investment focus
- Software, Energy, Renewable Energy
- Seed, Pre-Seed, Funding Round
- Germany, Switzerland, Finland
Portfolio highlights
- Ostrom — We make energy fair, smart and green - one flexible monthly plan with no hidden fees, digital-first and 100% renewable energy.
- Milvus Advanced — Our Midas-touch alloys replicate the functional properties of platinum-group metals at a fraction of the cost.
- Zymvol Biomodeling — Physics-AI hyperrealistic enzyme discovery. ZYMVOL helps R&D managers uncover hidden opportunities and screen areas overlooked by traditional methods.
Founded in 2010, TSVC (formerly TEEC Angel Fund) is proud to be a leading early-stage venture capital fund in Silicon Valley.
Show more
Investment focus
- Software, Artificial Intelligence, Health Care
- Seed, Funding Round, Series A
- United States, China, Canada
Portfolio highlights
- Lumotive — Lumotive is a Seattle-based startup company developing high performance, solid-state lidar for autonomous systems in the automotive, UAV, robotics and related industries. The company's revolutionary beam-steering technology leverages Liquid Crystal Metasurfaces (or LCMs) implemented in mature semiconductor manufacturing processes to deliversmall, inexpensive 3D perception systems with unprecedented performance and reliability. For more information, visit us at www.lumotive.com.
- Petal Surgical — Petal is a surgical technology company pioneering incisionless surgery through Acoustic Sculpting, a proprietary form of boiling histotripsy. Our platform uses focused sound waves to precisely destroy harmful tissue without cuts, heat, or toxicity offering gentler alternative to traditional surgery.
- Carbon Free Energy Cloud — Carbon Credits Simplified
Fundamental Equity Investing, since 1998
Show more
Investment focus
- Biotechnology, Machine Learning, Finance
- Funding Round, Series A, Series B
- United Kingdom, Austria, United States
Portfolio highlights
- Nattergal — Nattergal is a company with a mission to deliver nature recovery at scale, to provide vital benefits for society and sustainable financial returns.
- G.ST Antivirals — G.ST Antivirals focuses on the development of antiviral drugs. G.ST Antivirals utilizes the viral dependency on the host cell metabolism and exploits this to design specific interventions counteracting viral nutrient supply.
- AMNIS Treasury Services — Check out your possibilities to transfer money abroad, collect international payments and exchange currencies all in one account. Make payments fast with amnis.
Cutting-edge venture capital firm supporting the early-stage entrepreneurs building global businesses.
Show more
Investment focus
- Software, Information Technology, Artificial Intelligence
- Seed, Series A, Pre-Seed
- Germany, United States, United Kingdom
Portfolio highlights
- Raus — Raus is a hospitality-tech startup that offers new opportunities to take a break from big city life. Raus serves as a welcome escape from the seemingly endless demands and constant stimuli of modern life with perfectly simple cabins, close enough for a spontaneous getaway, far enough away to completely unwind.
- Ixana — Ixana operates as a wearable hardware company, that develops human-computer interfaces.
- Lyceum — Introducing the smartest way to train your models in the cloud. The electricity socket for your infrastructure needs.
R42 Group is a venture fund and an institute which invents, invests and informs covering AI, deep science, 5G mobile, biotech and fintech.
Show more
Investment focus
- Biotechnology, Health Care, Information Technology
- Seed, Funding Round, Pre-Seed
- United Kingdom, United States, Austria
Portfolio highlights
- Healx — At Healx we use AI drug discovery to develop new treatments for rare diseases. We bring treatments from prediction to patient.
- xWatts — xWatts is an intelligent energy management software that reduces energy costs and emissions in commercial buildings.
- Senisca — Developing a new generation of senotherapeutic interventions to target the diseases and aesthetic signs of ageing.
SPV
Show more
Investment focus
- Biotechnology, Health Diagnostics
- Seed
- Austria
Portfolio highlights
- Sola Diagnostics — Product: Sola Diagnostics’ WID®-easy test is a non-invasive epigenetic solution for detecting endometrial cancer in women with abnormal uterine bleeding. By analyzing DNA methylation markers from a simple vaginal swab, it offers high accuracy, reducing false positives and unnecessary surgeries. Target Audience: Designed for gynecologists andhealthcare providers, WID®-easy streamlines diagnostics, cutting costs and false alarms. Women benefit from a painless, accessible test that ensures earlier and more precise detection. Technology: Powered by advanced DNA methylation research, WID®-easy identifies cancer-specific epigenetic markers. With PCR-based analysis and robust clinical validation, it delivers fast, reliable results that integrate seamlessly into medical workflows. Market Positioning: WID®-easy fills a critical gap as a first-line diagnostic for abnormal uterine bleeding. Its clinical validation, accuracy, and cost-efficiency set it apart from invasive procedures. Its ease of use and scalability position it for widespread adoption. Milestones: Sola Diagnostics launched in Austria and Switzerland in 2024 and expanded to Great Britain in 2025. UKCA Marking was registered in December 2024. So far, private equity investments totaling €2.4M have supported Sola's mission to revolutionize women’s health diagnostics.
APEX Ventures is an early-stage venture capital fund that invests in start-ups grounded in unique and protectable technology. They provide support and resources and aims to develop their start-ups in their respective field. Their initial focus areas include digital media, business intelligence, cybersecurity, fintech, and the future of work.
Show more
Investment focus
- Artificial Intelligence, Health Care, Software
- Seed, Series A, Pre-Seed
- Germany, United Kingdom, Austria
Portfolio highlights
- Quibim — Leading radiomics company pioneering quantitative imaging biomarkers and medical applications in precision medicine.
- Robeaute — Redesigning the future of neurosurgery by creating the new standard device that will provide surgeons with seamless access to delicate areas of the brain parenchyma and with real-time data.
- HyperHeat — HyperHeat is building a cutting-edge, all-electric heating solution designed to reach temperatures of up to 2,000°C. Using renewable electricity HyperHeat is providing an efficient alternative to fossil fuel combustion. With an efficiency rate of up to 98%, HyperHeat is ideal for retrofitting industrial processes, enabling significant CO2reductions across industries like steel, cement, and chemicals. The scalable technology offers a cost-efficient approach to decarbonizing thermal processes, with a potential to reduce global CO2 emissions by over 4.5 gigatons annually.
We back B2B software and life-sciences companies with limitless scalability.
Show more
Investment focus
- Software, Biotechnology, Telecommunications
- Funding Round, Seed
- Austria, Germany
Portfolio highlights
- Txture — Txture is an end-to-end cloud transformation platform for planning transformations, migration management and cloud infrastructure optimization.
- a:head bio — a:head aims to develop new therapeutics for the treatment of brain disorders based on human cerebral organoids
- HeartBeat.bio — HeartBeat.bio is a privately funded drug discovery company focusing on the development of a high-throughput 3D screening platform for heart failure and cardiomyopathies.
bmp Ventures is an innovative Venture Capital Company from Berlin.
Since 1997 we’ve been investing Smart Money in Early Stage and Growth Startups. We finance ingenious business models with outstanding teams, who build fast-growing and sustainably profitable enterprises.
Show more
Investment focus
- Software, Information Technology, Manufacturing
- Seed, Funding Round, Series A
- Germany, United States, Austria
Portfolio highlights
- CYNiO — CYNiO is an innovative chemical startup dedicated to revolutionizing the production of isocyanates through a safe, flexible, and sustainable approach.
- NorcSi GmbH — Entwicklung von neuartigen Batterietechnologien
- byte robotics — Byte Robotics developed a springboard innovative software technology for robot program generation.
ARAX Capital Partners is an Austrian bio-tech and high-tech early stage investor with an exclusive focus on Austrian ventures. Companies need to be young, innovative (if possible with patentable technology) and must have already secured pre-seed funding to qualify for an investment
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Seed, Funding Round
- Austria
Portfolio highlights
- AFFiRiS — AFFiRiS AG, a Vienna, Austria-based developer of tailor-made peptide vaccines for Alzheimer's disease, Atherosclerosis, Parkinson's disease, hypertension and several other conditions.
- Greenpass — Greenpass is a ClimateTech company providing the official greenpass for climate proof real estate. Build resilience and manage climate-proof assets and portfolios in line with ESG regulations while maximizing return on invest and value with ease.
- Calyxha Biotechnologies GmbH — A new perspective on inflammation
The Austrian Research Promotion Agency (FFG) is the national funding agency for industrial research and development in Austria. As a "one-stop shop" offering a diversified and targeted programme portfolio, the FFG gives Austrian businesses and research facilities quick and uncomplicated access to research funding.The FFG was foundedon 1 September 2004 (pursuant to the FFG Act on establishing a research promotion agency, Federal Law Gazette I No. 73/2004). The FFG is wholly owned by the Republic of Austria, represented by the Federal Ministry for Transport, Innovation and Technology (bmvit) and the Federal Ministry of Science, Research and Economy (BMWFW). As a provider of funding services, however, the FFG also works for other national and international institutions.
Show more
Investment focus
- Software, Artificial Intelligence, Health Care
- Grant, Seed, Pre-Seed
- Austria, United States, Belgium
Portfolio highlights
- Chatlyn — Automated, AI-enhancend guest engagement, where your clients are most comfortable.
- OPTIMUSE — Optimuse provides an AI-based solution that supports the pre-design phase of building renovation. The platform converts building data into a digital twin to create accurate models for planning. It integrates data such as room types, thermal properties, and HVAC systems. The system runs energy simulations to calculate heating, cooling, lighting, andequipment needs. It helps design technical systems by defining the quantity, sizing, and configuration of components. The platform develops renovation plans by modeling financial, energy, and emissions outcomes. It also offers tools for cost calculation, performance monitoring, and collaboration across project teams.
- Cycuria Therapeutics — While new therapies, such as FLT3 inhibitors and venetoclax-based regimens, have improved initial response rates, durable remissions and long-term survival
BackBone Ventures' focus are early-stage investments, primarly in the area of innovative ICT, FoodTech and disruptive technologies in DACH & Israel.
Committed to achieve a positive impact for the next generation by empowering access to proficient ventures investments.
Show more
Investment focus
- Information Technology, Artificial Intelligence, Software
- Pre-Seed, Seed, Series A
- Switzerland, Germany, Israel
Portfolio highlights
- Neon — With neon, you can pay, save and manage your money. Digitally, securely and with no hidden fees. Open your account online in less than 10 minutes!
- Evoralis — Evoralis is an enzyme development company that specializes in the discovery and development of plastic-depolymerizing enzymes. It is a spin-out from the University of Cambridge.
- Proofcheck — Proofcheck is a multilingual AI proofreading platform and a collaborative in-browser workspace for PDFs and epubs. Their next-generation AI workflow and collaboration tool helps content creators quickly catch costly mistakes before they reach audiences. Proofcheck is headquartered in Vienna, Wien and was founded in 2022.
We deploy early stage capital to fuel the growth of need-driven health technology companies.
Show more
Investment focus
- Health Care, Artificial Intelligence, Medical
- Seed, Pre-Seed, Series A
- United States, United Kingdom, Germany
Portfolio highlights
- Datamonk — AI-powered PACS migration platform that automates secure and fast transfers of medical imaging data. Migrate up to 10TB per day and use AI agents for data validation and quality assurance.
- io Health — Io Health Technologies LLC provides AI-driven tools for home health documentation and workflow automation in healthcare.
- Sober Sidekick — Gamified peer to peer support
APEX Ventures is a deep-tech and medical-focused venture capital firm.
Show more
Investment focus
- Artificial Intelligence, Health Care, Software
- Seed, Series A, Pre-Seed
- Germany, United Kingdom, Austria
Portfolio highlights
- GEMESYS — Gemesys creates a chip that functions similarly to the human brain in order to overcome processing constraints and empower AI with the hardware it needs to complete its destiny
- HyperHeat — HyperHeat is building a cutting-edge, all-electric heating solution designed to reach temperatures of up to 2,000°C. Using renewable electricity HyperHeat is providing an efficient alternative to fossil fuel combustion. With an efficiency rate of up to 98%, HyperHeat is ideal for retrofitting industrial processes, enabling significant CO2reductions across industries like steel, cement, and chemicals. The scalable technology offers a cost-efficient approach to decarbonizing thermal processes, with a potential to reduce global CO2 emissions by over 4.5 gigatons annually.
- TriLite Technologies — The world's smallest projection displays from TriLite take laser beam scanning technology to the next level, for augmented vision as light as the eyewear of today.
| Investments that move industries
Show more
Investment focus
- Software, Apps, Information Technology
- Seed, Series A, Funding Round
- Austria, Germany, United States
Portfolio highlights
- Podero — Podero energy flexibility software helps utilities steer devices, trade their flexibility on spot and balancing markets and launch new energy products.
- UniteLabs — UniteLabs provides the foundational operating system for AI-driven lab automation in life science. It accelerates scientific discovery by closing the loop with a unified data and automation infrastructure, seamless integration, and intelligent control. Our platform empowers ambitious biotech companies, big pharma, integrators, and hardware vendorsby offering bidirectional connectors for diverse lab equipment, a scalable cloud platform with an open API, and a powerful workflow engine with an integrated compute environment. This allows for the creation of sophisticated, modular workflows, and enables rapid automation development through our Lab-as-Code environment, featuring a dynamic Python SDK and application-specific libraries.
- Circonomit — Building the world's environmental data infrastructure - We are the sustainability counterpart to what Excel, Sheets and Datev are to financial planning and accounting. Our mission is to create the first decision intelligence platform to bridge sustainability and finance by building the global standard for the collection and aggregation ofcorporate environmental data.
The European Venture Fund that backs gender-diverse founder teams.
Show more
Investment focus
- AgTech, EdTech, Software
- Pre-Seed, Seed
- Austria, United Kingdom
Portfolio highlights
- Circonomit — Building the world's environmental data infrastructure - We are the sustainability counterpart to what Excel, Sheets and Datev are to financial planning and accounting. Our mission is to create the first decision intelligence platform to bridge sustainability and finance by building the global standard for the collection and aggregation ofcorporate environmental data.
- KOA Biotech — Detecta enfermedades a tiempo y maximiza tus resultados.
- Willow Stories — Preserve your legacy and honor loved ones by creating lasting memorials.
Lansdowne Investment Company Cyprus
Show more
Investment focus
- Life Science, Biotechnology, Semiconductor
- Seed
- Austria
Portfolio highlights
- Sarcura — Sarcura GmbH is an Austrian deep-tech startup developing an instrument platform for the industrial manufacturing of advanced cell therapies. Our platform combines silicon chip technology and microfluidic processing to enable real-time process control and manipulation on a cellular level, enabling a fully automated and modular manufacturing system..
EIT Health is a network of best-in-class health innovators backed by the EU. We deliver solutions to enable European citizens to live longer, healthier lives.
Show more
Investment focus
- Health Care, Medical Device, Medical
- Grant, Pre-Seed, Seed
- United Kingdom, Spain, Ireland
Portfolio highlights
- Ochre Bio — Ochre Bio is developing therapies for the biggest liver health challenges.
- ZiO Health — ZiO Health develops multi-functional electronic devices for measuring, testing and detecting the molecular composition of chemical and biological substances for the presence, absence, or quantity of target molecules.
- Nanordica Medical — Nanordica Medical develops novel nanoparticle-based antibacterial wound care products.
INVEST AG is the investment arm of the Raiffeisen bank group of Upper Austria and is one of Austria’s leading private equity funds, managing a volume of 180 million euros. As an evergreen fund with an indefinite term, we are able to provide long-term stability and a solid foundation for future success, which is particularly relevant for anincreasing number of medium-sized companies facing a growing need for equity.The benefits of private equity:No personal liability of the partners
No securities to weigh you down
Greater risk capacity
Since its founding in 1994, INVEST AG has already invested equity and mezzanine capital in more than 140 companies in a wide variety of sectors. Currently, 26 companies in Austria and the south of Germany trust in our expertise and benefit from our support in operational, commercial, and strategic matters.Whatever situation you find yourself in as a company and whatever problem you are seeking a custom-made solution to, be assured that you will always find us to be a highly experienced and reliable partner.
Show more
Investment focus
- Security, Hospitality, Food and Beverage
- Seed, Private Equity
- Austria, United States
Portfolio highlights
- NEOH USA — NEOH USA is a fast growing new food brand from Kirkland, WA and the leader in Crossbars. It satisfies your sweet tooth without the guilt. Crossbars taste as great as a candy bars but are protein bars.
- HeartBeat.bio — HeartBeat.bio is a privately funded drug discovery company focusing on the development of a high-throughput 3D screening platform for heart failure and cardiomyopathies.
- RadarServices — RadarServices is the European market leader for proactive IT security monitoring and IT risk detection as managed services. The services uniquely combine automated detection of security relevant issues and risks with the analysis and assessment done by experts. Data never leaves the clients‘ premises.
Investing at the intersection of climate and health.
Show more
Investment focus
- Software, Biotechnology, Information Technology
- Seed, Funding Round, Pre-Seed
- United States, Germany, Austria
Portfolio highlights
- Cellbyte — AI Agents for Pricing and Market Access Teams in the Pharmaceutical Industry.
- Vema Hydrogen — Vema Hydrogen is a pioneering clean hydrogen production company. It helps to fight the enormous decarbonization issue.
- ChemFinity Technologies — ChemFinity Technologies is a chemical company that offers critical metal recovery, water purification, and gas separation services.
venture capital
Show more
Investment focus
- Software, Biotechnology, Information Technology
- Seed, Series A, Series B
- Hungary, South Korea, United States
Portfolio highlights
- Iskra — Iskra offers web3 gaming opportunities using blockchain and rewards its stakeholders based on their participation.
- On Vacation — On Vacation is a chat-based concierge service where customers may get help making reservations and getting personalized and optimal tours from travel specialists.
- NextChapter — NextChapter is a digital commerce platform that acquires and operates Coupang and Naver-based online native brands in Korea. NextChapter is backed by BlueRun Ventures/BRV Capital Management, Goodwater Capital, Klim Ventures, Fast Ventures and Sandbox Network.NextChapter was founded in 2021 by Joshua Kwon and Jay Chung and is headquarteredin Seoul, Korea.
Wir wollen unser wichtigstes Erbe erhalten. Eine lebenswerte Erde.
Show more
Investment focus
- Farming, Renewable Energy, Solar
- Seed, Grant, Pre-Seed
- Switzerland, Germany, Austria
Portfolio highlights
- Planeteers — We capture CO2 in water and unleash the potential of the oceans as the largest carbon sink on our planet.
- Infrascreen — The transparent aluminium screen for extra energy-savings in greenhouses. Thanks to it's low-e coating, it saves up to 20% more than a regular energy-saving screen
- Kynda — Keen 4 Greens offers a wide range of vegan products. Founded in 2019, Keen 4 Greens is based in Hamburg, Germany.
Financing for startups in Styria
Show more
Investment focus
- Software, Audio, Travel
- Seed, Grant, Funding Round
- Austria
Portfolio highlights
- teamazing — Unlock your team's full potential! Tailored workshops, tools & events for continuous team development. Analyze, build, and grow with teamazing!
- Busfinder.com — Reisebus mieten mit Fahrer. Bus Angebote von Busunternehmen vergleichen und online buchen. Jetzt Bus buchen auf busfinder.com
- Delphi Data Labs — Unlock your hidden market potential and use your data to its fullest potential. We offer everything from market analysis, data modelling and vizualization to system integration in your existing technical environment to super-charge your decision-making.
We are peers amongst entrepreneurs helping the brave to build game-changing companies, just like we have done ourselves.
Show more
Investment focus
- Software, SaaS, Artificial Intelligence
- Seed, Series A, Series B
- Germany, France, Sweden
Portfolio highlights
- Codesphere — Codesphere is your Zeroconfig Cloud. No config - just code and run web apps from your browser. Team work on distributed full stack Typescript, and benefit from our automatic deployments, scaling, tests, and security / privacy audits. We optimize each and every detail to keep things simple for you. Codesphere is next level programming.
- simplyblock — High-performance storage software designed for databases with low latency, high scalability and high IOPS. NVMe-optimized. Alternative SAN or EBS. Scalable Block Storage software. Simplyblock | Simply Block | Simplyblock Block Storage
- Go Autonomous — Unlock advantages of Autonomous Commerce and experience heightened efficiency, reduced costs, and seamlessly interaction for both buyers and sellers.
GCP Gamma Capital Partners is a private Venture Capital investment and Equity consulting firm established in 2002 (GCP Presentation 2020). We focus on dynamic technology and growth companies in Austria, Germany, Switzerland and CEE countries bordering Austria. We aim for value creation and value realization to generate superior returns for our investors and clients.
Show more
Investment focus
- Mobile, iOS, Mobile Apps
- Series A, Seed, Series C
- Austria, Switzerland, United States
Portfolio highlights
- Wikitude — Wikitude Augmented Reality empowers your iOS, Android & Smart Glasses apps with Image & Object Tracking, Instant tracking (SLAM), Geo AR, and more.
- 42matters AG — 42matters offers a full suite of mobile and connected TV app intelligence solutions, including APIs, file dumps, and visual, web-based platforms.
- Organica Water — Organica Water is a global provider of innovative solutions for the treatment and recycling of wastewater. Over the past two decades Organica has developed a truly unique approach, enabling customers all over the world to build and operate space and energy efficient biological wastewater treatment plants (WWTPs) that blend harmoniously into urbanand residential population centers, ultimately lowering infrastructure costs and facilitating reuse and recycling of treated wastewater. Established in 1998, Organica began as a traditional wastewater design-build company focused exclusively on the Hungarian market. During the first nine years of its life the company built over 75 municipal, commercial, and industrial WWTPs using a variety of different technologies, while continually investing into R&D to futher develop its own IFAS-type solution for biological wastewater treatment. In 2007 Organica sold it's design-build business to focus exclusively on the commercialization of its own biological wastewater treatment solution on a global basis. Today, Organica is an international company operating on three different continents, and the world leader in Fixed-Bed Biofilm Activated Sludge (FBAS) technology,with more than 25 operating references all over the world, and nearly a dozen additional Organica-powered WWTPs currently under construction.
Matthias Wilrich is the VP Vehicles and Supply Chain at TIER Mobility.
Show more
Investment focus
- E-Commerce, Delivery Service, Mobile Apps
- Seed, Pre-Seed, Series A
- Germany, Austria, Malaysia
Portfolio highlights
- Lumaly — Lumaly is a browser extension that automatically tries out and uses all available voucher codes in the cart when shopping online.
- MAYD — MAYD provides telepharmacy platform providing healthcare-related goods in a convenient way by delivering it to doorstep.
- HELLO INSIDE — HELLO INSIDE is a scientific self care company empowering people to have data-driven conversations with their bodies. Unlock your best self.
Santo Holding is a Zurich-based investment firm funding biotechnology, pharmaceutical, life sciences, and healthcare companies.
Show more
Investment focus
- Biotechnology, Energy, Medical
- Funding Round, Series B, Series C
- Germany, Austria
Portfolio highlights
- AFFiRiS — AFFiRiS AG, a Vienna, Austria-based developer of tailor-made peptide vaccines for Alzheimer's disease, Atherosclerosis, Parkinson's disease, hypertension and several other conditions.
- SuppreMol — SuppreMol is a privately held biotechnology company that pioneers a novel approach for the treatment of autoimmune diseases which could lead to the cure of these disorders instead of merely treating their symptoms.
- Efficient Energy — Efficient Energy GmbH is an innovative manufacturer and system supplier of environmentally friendly refrigeration technology, based in Feldkirchen near Munich, Germany. The company developed the Bluezero-technology, which uses water as a refrigerant and and thereby entirely avoids fluorinated refrigerants (HFCs). Efficient Energy helps itscustomers overcome the increasing regulatory challenges of refrigeration technology, and offers them long-term, sustainable solutions with its eChiller model range. The eChiller chilled water units are ideally suited for process cooling, machine cooling and the cooling of technical equipment and data centres and provide cooling capacities from 35 kW to 120 kW, depending on the model. With its outstanding cost efficiency and low CO2 footprint, companies benefit on many fronts. The pioneering technology has also been noticed by politics and the media, and has received multiple awards for the eChiller. These include among others the European Business Award for the Environment 2018/2019 from the European Comission and the Red Herring Europe Top 100 in 2020.
ICL Startup Accelerator focuses on foodtech and crop nutrition startups, innovative products, and accelerates their market penetration
Show more
Investment focus
- Biotechnology, Agriculture, Organic Food
- Seed
- Israel, Austria
Portfolio highlights
- Lavie bio — LaVie Bio develops bacterial compositions that are sprayed on plants, used to coat seeds, or are integrated in the soil around the plant in order to improve the crop or the plant's features.
- Arkeon Biotechnologies — Arkeon converts CO2 into resources to power tomorrow's industries.
HCVC is an early-stage Venture Capital firm backing hardtech companies worldwide. Beyond its fund, HCVC supports hardtech founders through Hardware Club, a selective global community of 500+ startups with dedicated resources, partnerships and events.
Show more
Investment focus
- Software, Robotics, Artificial Intelligence
- Seed, Series A, Pre-Seed
- United States, France, United Kingdom
Portfolio highlights
- Karman+ — Mining near Earth asteroids
- Alpine Eagle — The Sentinel Counter-UAS System is an air-to-air sensor & interceptor network designed to detect, classify, and intercept unmanned aerial systems (UAS)
- Fuse Vectors — Fuse Vectors is disrupting the manufacturing process in order to provide universal access to gene therapy.
Investing in the ReGeneration
Show more
Investment focus
- Agriculture, Biotechnology, Farming
- Seed, Series A, Series B
- United States, Austria, United Kingdom
Portfolio highlights
- Anthrogen — Anthrogen is a Biotechnology Research firm using bacteria and enzymes for reducing carbon in the air by transforming it into chemicals.
- PACT — PACT designs Elegant materials produced in tune with the planet earth. It create revolutionary, sustainable biomaterials using the earth's resources, including collagen, herbal extracts, oils, and minerals.
- Ulysses Ecosystem Engineering — Ulysses rewild the ocean and remove gigatons of carbon, contributing to global efforts to combat climate change and restore marine ecosystems.
Tet Ventures is one of the most active global food-tech investors. We work with and invest in technology that can improve the food system.
Show more
Investment focus
- Food and Beverage, Biotechnology, E-Commerce
- Seed, Pre-Seed, Funding Round
- United States, Germany, United Kingdom
Portfolio highlights
- Afterlife Ag — Eliminate organic waste from going into landfills. Peat upcycles your food waste into fresh, sustainable, and delicious mushrooms.
- FORAY bioscience — FORAY bioscience is a biotechnology company that uses biomanufacturing techniques to produce wood products.
- Prolific Machines — Difficult protein production made simple. A next-generation expression system for next-generation therapeutics.
Possible Ventures backs ambitious teams building frontier technology to positively impact society. We invest globally in the early stages, actively supporting founders via our collective of global entrepreneurs.
Show more
Investment focus
- Software, Information Technology, Biotechnology
- Seed, Pre-Seed, Series A
- Germany, Australia, United States
Portfolio highlights
- tozero — Truly bringing lithium-ion battery waste tozero by recovering all critical matierlas, like lithium, nickel, cobalt, manganese, and graphite.
- HyperHeat — HyperHeat is a climate tech startup, that develops a breakthrough solution for zero-carbon industrial heat at very high temperatures.
- Hippos Exoskeleton — Hippos Exoskeleton created an auto-inflating knee brace to avoid tears in the ACL and other injuries.
Andera Partners, formerly known as Edmond de Rothschild Investment Partners (EdRIP) As heir to the traditions and values that have ensured the success of the Rothschild family for 250 years, the Edmond de Rothschild Group has established itself over time as a leading player in European finance. Its activities are grouped around two major areas:Private Banking and Asset Management. The Group offers wealthy families, entrepreneurs, and large institutions a full range of solutions combining a culture of tailored solutions, stability, performance, and innovation.
The Edmond de Rothschild Group’s offering is characterised by strong convictions, with the desire to guarantee to each of its customers: A unique, close relationship, underpinned by the know-how and the variety of expertise of a large international group; Autonomous, experienced teams, who anticipate economic trends and innovate to establish long-term performance; The recognised stability, strength, and independence of a family-owned financial group. Founded by Baron Edmond de Rothschild in 1953, the Group has been chaired by his son, Baron Benjamin de Rothschild, since 1997.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series B, Private Equity, Funding Round
- France, United States, Germany
Portfolio highlights
- Nouscom — Nouscom is a next-generation immunotherapy company developing genetic cancer vaccines and oncolytic viruses..
- Qualisteo — Qualisteo, a start-up company based in Nice specialised in smart grids company.
- mylight150 — Mylight150 contributes to the creation of a society in which people generates own electricity to ensure self-sufficiency and long-term abundance.
MCI Capital is a leading Digital Private Equity investor in CEE, based in Warsaw, Poland. MCI Capital seeks to invest in digital disruption, transformation and infrastructure within EU, with focus on CEE. Preferred sectors are SaaS, E-commerce, Marketplace, Fintech, Insurtech, Foodtech, Traveltech and Digital Infrastructure. MCI typically investsEUR 25-100 M in a single project, either in Buyout or Expansion stage. Historically, MCI Capital has also been involved in funds dedicated to Private Debt, Growth and Venture Capital areas – these funds do not conduct any new investments, instead they focus on building the value of assets and de-investing.MCI Capital is managed by the executive management team. The company is listed on the Warsaw Stock Exchange since February 2001 and is also a member of the Polish Private Equity Association.
Show more
Investment focus
- E-Commerce, Software, Mobile
- Series A, Funding Round, Seed
- Poland, Germany, United Kingdom
Portfolio highlights
- IdoSell —
- Gett — Gett is a technology platform focused on corporate Ground Transportation Management (GTM), where spend is estimated to exceed $100 billion globally. https://gett.com/why We are the GTM category leader, serving over a quarter of the Fortune 500 companies.Gett’s cloud-based software organizes thousands of transportation providers(corporate fleet, ride-hailing, taxi, and limos) into one single platform. The technology helps save businesses time and money by managing all their ground transportation spend, and optimizes the entire employee experience from booking and riding to invoicing and analytics.We are building the first ground transportation grid available to customers worldwide, similar to telephony and internet grids, with aspirations to become the standard in corporate ground transportation, just as Zoom became the standard in corporate communication.Founded in 2010 and headquartered in London, Gett has raised more than $750M in funding to date, including more than $300M from the Volkswagen Group. They employ over 800 employees globally.
- ANSWEAR.com —
Kale United offers a portfolio of over 75+ plant-based game changers
Show more
Investment focus
- Food and Beverage, Food Processing, Biotechnology
- Seed, Pre-Seed, Funding Round
- United Kingdom, Sweden, India
Portfolio highlights
- Opalia — Opalia is introducing a new era of dairy: functional, delicious, and sustainable dairy made from mammary cells.
- The Pack — Nutritionally complete vegan dog food. Grain-free & developed with food scientists & animal nutritionists, try our delicious vegan dog food now.
- Cultimate Foods — Cultimate Foods is a cellular agriculture company. It develops cultivated fat for hybrid alt-meat products. It's cultivated fat replicates the structure of animal fat tissue and it uses a "unique technological approach to 3D cultivation that creates the structure of their ingredient and reduces production costs."
Entrepreneurs for Entrepreneurs
Show more
Investment focus
- Software, Information Technology, Artificial Intelligence
- Seed, Series A, Funding Round
- Austria, Switzerland
Portfolio highlights
- Respory — Respory provides real-time people-tracking using proprietary radar sensors, all without capturing personal data. Our scalable sensor network, powered by AI-driven algorithms, delivers precise customer journey insights, critical for in-store performance in retail.
- Teragon — Laser Metrology for Steel Rolling Mills. Engineered in Graz, Austria.
- aTension.life — aTension.life is a company focused on advancing the diagnosis and treatment of hypertension through precision medicine. It employs cutting-edge mass spectrometry technology to identify the underlying causes of uncontrolled hypertension using a single blood sample. aTension.life aims to provide personalized diagnostic solutions that enhance patientcare and support laboratories with accurate and reliable tools. The company's mission is to improve the quality of life for hypertensive patients by making advanced diagnostics widely accessible and enabling more effective, individualized therapies.
Gateway Ventures is Austria's biggest network of startup investors with currently over 4000 investors. We foster the Austrian and European startup eco-system by connecting investors and startups. Our startup portfolio covers FinTech, CleanTech, HeathTech, IT & Software, Big Data & Social Impact. We have financed >40 startups withseed fundings over € 30M+Gateway Ventures was founded in December 2015. Over 1000 investors and 200 partners are currently participating in the network, including European incubators, accelerators and VCs.https://www.gateway.ventures
Show more
Investment focus
- Software, Information Technology, Apps
- Seed, Series A, Funding Round
- Germany, Austria, Estonia
Portfolio highlights
- Mediaire — mediaire supports radiologists with AI-based tools for MRI reporting. This enables them to make a more accurate and objective assessment even faster.
- Pilzling — Bio-Pilze direkt aus deiner Stadt.
- LipoCheck — LipoCheck is a healthtech startup that focuses on improving the diagnosis and treatment of lipedema, a condition that affects millions of women. The company offers a digital platform that serves as a support system for patients and treating physicians. LipoCheck's services include helping patients recognize lipedema and providing assistance inbecoming symptom-free. The platform was developed with the experiences of practicing doctors, product managers, and software developers. In addition to its digital services, LipoCheck also offers a range of merchandise including hoodies and shirts.
VP Venture Partners is a venture capital firm invests in healthcare companies.
Show more
Investment focus
- Medical, Health Care, Biotechnology
- Seed
- Austria
Portfolio highlights
- aTension.life — aTension.life is a company focused on advancing the diagnosis and treatment of hypertension through precision medicine. It employs cutting-edge mass spectrometry technology to identify the underlying causes of uncontrolled hypertension using a single blood sample. aTension.life aims to provide personalized diagnostic solutions that enhance patientcare and support laboratories with accurate and reliable tools. The company's mission is to improve the quality of life for hypertensive patients by making advanced diagnostics widely accessible and enabling more effective, individualized therapies.
4SC discovers and develops targeted, small-molecule drugs for the treatment of cancer and autoimmune diseases in indications with high unmet medical needs. These drugs are intended to provide innovative treatment options that are more tolerable and efficacious, and provide a better quality of life.
Show more
Investment focus
- Health Care, Biotechnology
- Seed
- Austria
Portfolio highlights
- Panoptes Pharma — Panoptes is a privately held biotech company focused on developing small molecule based therapies for the treatment of severe eye diseases with high unmet medical need. Panoptes is located in the city center of Vienna, Austria.The development of Panoptes´ clinical candidate PP-001 focuses on a new treatment for autoimmune uveitis, a disease whichis one of the major causes of blindness. As a second indication, adenoviral conjunctivitis will be pursued, a disease for which to date, no treatment is available. Due to its unique mode of action, PP-001 has therapeutic potential for additional inflammatory and viral indications.Panoptes has an experienced team of development experts with a proven track record of developing and commercializing innovative products. The team is developing a focused portfolio of high-performance small molecule products, with its lead clinical candidate PP-001 in preclinical development.
Air Street Capital invests in AI-first companies.
Show more
Investment focus
- Artificial Intelligence, Machine Learning, Biotechnology
- Seed, Series A, Pre-Seed
- United States, United Kingdom, Canada
Portfolio highlights
- Sereact — Discover the world's easiest pick and place automation solution. Significant cost savings, productive 24/7, deployment in one day and no training required.
- Fern Labs — Deploying agents at the scale of real world problems
- Odyssey — We're pioneering world models, the next frontier of artificial intelligence.
Investors by industry
Community
Artificial intelligence
Hardware
Marketplace
Consumer
FinTech
Energy
Gaming
Impact
Climate
Proptech
Google
Biotech
Health Care
EdTech
Sustainability
Venture Capital
Clean Energy
Art
Web3
Organic Food
Wellness
Android
Big Data
Video Games
Publishing
Digital Media
B2B
Food and Beverage
Manufacturing
Payments
Real Estate
Finance
Construction
Education
Financial Services
Retail
Infrastructure
Sports
Beauty
Photography
Franchise
Biotechnology
eSports
Travel
Fitness
Recruiting
Hospitality
Mobile
Mobile Advertising
Enterprise Software
Platforms
Cannabis
Music
Automotive
Social
Email
Wine And Spirits
Medical Device
Social Media
Crowdfunding
Social Network
CleanTech
Mobile Apps
Transportation
Medical
InsurTech
Enterprise
Legal
Local
LGBT
Internet
SaaS
Oil and Gas
Fashion
Film
Life Science
Theatre
Non Profit
Renewable Energy
Sporting Goods
Restaurants
Software
Social Impact
Celebrity
Facebook
Cryptocurrency
Machine Learning
Agriculture (agtech)
Media (entertainment)
Blockchain
Investors by country
New Zealand
Ireland
Canada
United States
India
Germany
United Kingdom
South Korea
Australia
Middle East
Indonesia
South Africa
Sri Lanka
Vietnam
Europe
Qatar
Japan
Singapore
Spain
China
Armenia
Saudi Arabia
Ghana
Oceania
Egypt
Africa
Belarus
Hungary
LATAM
Finland
Asia
France
Brazil
Croatia
Gibraltar
Liechtenstein
Barbados
Georgia
Panama
Greece
Czech Republic
Myanmar
Faroe Islands
Lithuania
Costa Rica
Hong Kong
Malaysia
Bahrain
Belgium
Peru
Denmark
Bermuda
Estonia
Liberia
Algeria
Jersey
Lebanon
Ecuador
Norway
Bulgaria
Belize
Chile
Mexico
Ethiopia
Togo
Rwanda
Slovenia
Italy
Poland
Uganda
Mali
Philippines
San Marino
Sweden
Serbia
Sierra Leone
Thailand
Israel
Tanzania
Uzbekistan
Zambia
Kuwait
Turkey
Uruguay
Mauritius
Tajikistan
Russian Federation
Portugal
El Salvador
Malta
Puerto Rico
Senegal
Morocco
Zimbabwe
Tunisia
Venezuela
Ukraine
Nicaragua
Taiwan
Dominican Republic
Bahamas
United Arab Emirates
Jamaica
Iraq
Honduras
Iceland
Isle of Man
Bolivia
Azerbaijan
Luxembourg
Nigeria
Pakistan
Namibia
Albania
Romania
Jordan
Grenada
Argentina
Bangladesh
Kazakhstan
Kenya
Cayman Islands
Cambodia
Cyprus
Oman
Latvia
Cameroon
Austria
Switzerland
Colombia
Guatemala
Seychelles
Marshall Islands
Investors in Austria by industry
Transportation
Music
Cryptocurrency
Education
Finance
Food and Beverage
Real Estate
Organic Food
Medical
Internet
Manufacturing
Wellness
Digital Media
Mobile
Android
Blockchain
Local
Software
Enterprise Software
Sports
eSports
Fitness
Automotive
Hospitality
Travel
InsurTech
Platforms
Recruiting
FinTech
Biotechnology
Consumer
Health Care
EdTech
Energy
Sustainability
Climate
Impact
Marketplace
Proptech
SaaS
Artificial intelligence
Gaming
Hardware
B2B
Mobile Apps
Web3
Life Science
Sporting Goods
Financial Services
Publishing
Biotech
Renewable Energy
Enterprise
Medical Device
Social Impact
Big Data
Social Media
Media (entertainment)
Art
Agriculture (agtech)
Machine Learning
Construction
Community
CleanTech
Retail
Payments